SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " CIE " 27,142 found 🔀 AI-powered Shuffle
A Massive Seaweed Belt Crosses the Atlantic. Scientists Are Rethinking What Feeds It
New studies point to ocean nutrients and recycling within the floating ecosystem.
Thwaites is a runaway climate disaster. New studies show how.
Melt from the "Doomsday Glacier" could drown coastlines around the world. And the outlook is getting even worse.
Ebola scientists to probe Nigeria case origin, Africa CDC says
By Jennifer Rigby LONDON, Oct 26 (Reuters) - A team of leading Ebola scientists will travel to Nigeria to help investigate how the country’s first patient in more than a decade got infected, Africa CDC Director-General Jean Kaseya said. Their task will...
Commentary: Parks can play essential role in disaster response
As climate change brings more wildfires, floods and heat emergencies, public parks have proven to be essential community infrastructure, yet they are still funded as optional amenities. That has to
Ecumenical Patriarch: Church and Medical Science are "partners" in serving life
Ecumenical Patriarch Bartholomew emphasized the importance of cooperation between the Church and medical science during his address at the Church of St. Theodore Tiron in Rome on Sunday, October 25, 2026, paying tribute to healthcare professionals for their service during the COVID-19 pandemic. The Ecumenical Patriarch presided over the Divine…
‘The best of the best’: CSU geologist Ellen Wohl plans for retirement after illustrious career
A university distinguished professorship and the 2026 Robert E. Horton Medal for significant contributions to hydrology are just a couple of Colorado State University Geology Professor Ellen Wohl’s the achievements. Beyond them, however, she said she is simply a woman with a deep passion for science. “My parents were teachers,” Wohl said. “My dad was a...
Research Roundup: Scientists restore bleached coral, engineer protein-based material, use AI to simulate drug effects
Read about the latest developments at Stanford in this week’s Research Roundup.
Goldwind Science & Technology: 9M26 profit reached RMB2.9 billion as WTG sales rose and backlog hit 57.0 GW
9M26 revenue was RMB52.0 billion and attributable net profit RMB2.9 billion. WTG sales rose 3.02% YoY, while total backlog reached 57.0 GW; operating cash flow was negative RMB30 million.Original document: Goldwind Science & Technology Co. Ltd. Class A [002202] Slides Release — Oct. 26 2026This is…
Netanyahu might be finished but his policies toward the Palestinians will largely endure
JALUD, West Bank (AP) — Israel's elections Tuesday could mark the end of Prime Minister Benjamin Netanyahu 's decades-long political career.But his legacy in the Israeli-occupied West Bank — of massiv...
Fabarta Unveils Major Upgrade to Its AI for Science Platform, Named Among Inaugural "Hong Kong Top Talent Ecosystem Partners" Ahead of Hong Kong FinTech Week
PR Newswire | Powered by the upgraded RSI engine, the platform unifi
All-male Nobel science outcome reignites gender equity concerns
Representative says changes to nominations seem to be working despite women missing out in 2026
HVEN Inbound: Dream 2 Science
Deep house duo Dream 2 Science play their first live show in Japan at HVEN in Nakameguro, Tokyo, on November 6.
What is optogenetics? The Nobel-winning science explained
From light to insight: Exploring optogenetics in brain science
Marco Rubio’s Greek Panegyric / Celebration: Political Theory and Praxis
Prologue Translating the ideals of Greek history, politics, democracy, theater, athletics, the Delphi peace vision, philosophy, science, technology,
Women’s football’s Black British icons
Our writers pay tribute to the Black British women who have left indelible legacies on the sport
Actuarial Science Club Meeting
We will be welcoming a guest speaker, Mackenzie Duckworth, who works at Milliman. Milliman is among the world's largest independent actuarial and consulting firms. It will be a wonderful opportunity
How to Manage Symptoms of Heart Failure
(Feature Impact) Americans are facing a growing health challenge, with 1 in 4 adults at risk of heart failure, according to the Heart Failure Society of America. Additionally, approximately 6.7 million U.S. adults who are 20 years old or older are currently living with heart failure, and that number is projected to reach 8.7 million by 2030. googletag.cmd.push(function() { googletag.display('JGFI_Article_300x250'); }); Managing heart failure is a significant expense to the U.S. healthcare system, costing the nation approximately $40 billion in 2020 and expected to increase to approximately $142 billion a year by 2050.If you (or a loved one) are living with the condition, consider these tips to help manage it.Adhere to the Treatment and Follow-Up PlanOngoing outpatient care is important when managing heart failure. Understand the treatment plan provided by your healthcare team, make diet and lifestyle changes, take medications as directed and keep recommended follow-up appointments.Pay attention to changes in symptoms and communicate with your healthcare provider if treatment does not seem to be working as expected. If their conditions are left unmanaged, patients can experience a range of heart-failure-related symptoms such as shortness of breath, fatigue, buildup of fluid and more.Understand Challenges with Diuretic TreatmentDiuretics help the body remove excess fluid and are commonly used to treat swelling, or edema, associated with heart failure. Your provider may try different diuretics, sometimes referred to as “water pills,” to manage your heart failure symptoms. However, intravenous (IV) diuretic therapy may be required for some patients if symptoms continue.Ask About Treatment Options Before IV Care Is NeededFor some adults, a healthcare provider may consider recommending an at-home, non-oral diuretic option prior to escalating to IV therapy.For example, ENBUMYST™ (bumetanide nasal spray) is a prescription diuretic used in adults to treat edema associated with congestive heart failure. It’s administered as a nasal spray for short-term use to manage excess fluid with the goal of transitioning to oral diuretic therapy when appropriate.Talk with your healthcare provider to learn more and visit enbumyst.com. Read the full Prescribing Information and Patient Information.Photo courtesy of Shutterstock googletag.cmd.push(function() { googletag.display('JGFI_Article2_300x250'); }); Important Safety InformationWhat is ENBUMYST?ENBUMYST is a prescription medicine used in adults to treat swelling caused by excess fluid in the body (edema) from congestive heart failure, liver disease, and kidney disease.What is the most important information I should know about ENBUMYST?ENBUMYST is a diuretic that helps your body remove fluid. Losing too much fluid can cause dehydration, low blood volume, and increase the risk of blood clots. Blood abnormalities may include decreased salts (electrolytes), and increased nitrogen, glucose and uric acid. The risk of these abnormalities is higher in elderly people, those using higher doses, or those who do not get enough electrolytes by mouth.You should not use ENBUMYST if you have severe electrolyte loss. Tell your healthcare provider if you experience unusual thirst; dizziness or lightheadedness; weakness or tiredness; fast heart rate; dry mouth or tongue; sudden pain; redness or swelling in your joints; pain, swelling, redness, or warmth in your leg; shortness of breath or fast breathing; high blood sugar; dark urine; pale, tight, cool or clammy skin; muscle cramps; confusion.Do not use ENBUMYST if you have low or no urine production or are allergic to bumetanide or to any of the ingredients in ENBUMYST.Before using ENBUMYST, tell your healthcare provider if you have low electrolytes, are on a low-salt diet, have diarrhea, diabetes, nasal problems such as a runny or stuffy nose or polyps, a history of nasal injury or surgery, are or plan to become pregnant, are or plan to breastfeed.Tell your healthcare provider about all the medicines you take, including prescriptions, over-the-counter medicines, vitamins, and herbal supplements.ENBUMYST may cause serious side effects, such as worsening kidney function and ringing in the ears or hearing loss.The most common side effects of ENBUMYST include dehydration, headache, muscle cramps, dizziness, low blood pressure, nausea, and abnormal brain functioning with certain liver problems.These are not all the possible side effects of ENBUMYST. Talk to your healthcare provider for more information.Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.US-ENBU-2600110 googletag.cmd.push(function() { googletag.display('JGFI_Article3_300x250'); });
Ministry of Science and ICT Probes Douzone Bizon Breach
Ministry of Science and ICT Probes Douzone Bizon Breach Public-Private Joint Investigation Team Formed to Assess Cybersecurity Impact
China's Rise in Science as a Source of Strategic Power
China is on course to lead the world in research and development, a shift with direct consequences for technological competition and the balance of global power. That is the conclusion of a news feature by Xiaoying You in Nature, published on October 14, 2026. The scale of the change is striking. In 1978, researchers in […]
Following the Science
Robert Royal: True science and faith complement each other by recognizing higher orders of reality.
New York Rallies for Health and Healing
United Hospital Fund and the American Cancer Society each celebrated their own heroes this October — doctors, philanthropists, and survivors alike — in two galas united by one cause: a healthier New York.
Can teaching people more about science increase public trust?
We hear about science outreach efforts in Cincinnati designed to spur interest — and the role moms play in shaping science policy.
Ornithologist John Weske devoted life to shorebird science
John S. Weske, whose long-term banding of royal terns and brown pelicans contributed to current understanding, died Oct. 18 at 90.
Graphic Medicine: How Comics Are Transforming Healthcare
Graphic medicine pioneer Ian Williams highlights how comics can communicate medical experiences, build empathy, and offer perspectives beyond textbooks.
Emad Shash: Beyond Science, It’s the People Who Make ESMO Special
Emad Shash: Beyond Science, It’s the People Who Make ESMO Special / Amalya Sargsyan, Arpi Asminian, cancer, Emad Shash, ESMO, esmo 2026, ESMO 26, Mona
Reimagining the future: Global experts gather in Beijing to rethink science museums in the age of AI
In today's AI era, where knowledge is easily accessible, the significance of science museums lie in invoking emotions, creating memorable experiences, and providing a space for reflection and meaningful dialogue, experts suggest.
Science behind virga, rain or snow that never reaches the ground
Science behind virga; rain or snow that never reaches the ground
World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial
"This has not been achieved before in the history of cancer drug development."
Scientists Reversed 60 Years of Cellular Aging. Can It Work in Humans?
Scientists reversed 60 years of cellular aging in a lab. As billionaires pour money into longevity research, could humans be next?
Corpus Christi Museum of Science and History turns Halloween into a hands-on learning experience for kids
The Corpus Christi Museum of Science and History made Halloween educational with hands-on activities, experts and a Mad Science Show.
Arizona business opens doors for employees with criminal records
An Arizona-based luxury door manufacturer is prioritizing hiring formerly incarcerated individuals to help them successfully re-enter society.
Wafik El-Deiry: Jennifer Doudna On What It Takes To Be a Good Scientist
Wafik El-Deiry: Jennifer Doudna On What It Takes To Be a Good Scientist / cancer, Jennifer Doudna, OncoDaily, Oncology, Wafik El-Deiry
Chinese scientists discover “D-rex,” a giant fungus with roots stretching back 65 million years
Scientists have discovered a giant new fungus in China that grows up to 20 inches tall and weighs nearly five pounds, making it the largest known of its kind. Dubbed “D-rex,” its evolutionary lineage appears to have emerged shortly after the dinosaurs went extinct, raising intriguing questions about how that ancient catastrophe may have shaped its evolution.
Scientists discover Arctic sea ice loss could be far worse than predicted
Arctic winter sea ice could disappear much faster than scientists previously expected, according to new research using climate clues from 6,000 years ago. By comparing ancient ocean sediments with modern climate models, researchers found that future winter ice coverage may be roughly one million square kilometers smaller than earlier predictions suggested.
Tiny magnetic vortices could help computers work more like your brain
Scientists have filmed tiny magnetic vortices called skyrmions melting out of an organized lattice for the first time, revealing new ways to manipulate these unusual structures. The breakthrough could help make brain-like computers a reality, potentially enabling dramatically smaller and more energy-efficient technology.
Global Scientist Mobility: Redrawing the Innovation Map
Global scientist mobility patterns reveal how knowledge networks evolve. Learn why policy must shift from attracting talent to enabling circulation.
Innovative food processing technique boosts Nebraska companies, educational outreach
Leadership and strategic visioning by Mary-Grace Danao, research associate professor in the Department of Food Science and Technology and the Department of Biological Systems Engineering, has helped position the University of Nebraska–Lincoln at the forefront of high pressure processing-focused food safety research in partnership with private industry.
UCLA Library's Data Science Center closed amid consolidation effort
UCLA Library dissolved its data consultation center and stopped offering data analysis services in August. The university consolidated the Data Science Center into UCLA Library’s research services unit as part of a broader effort to restructure the department, a UCLA Library spokesperson said in an emailed statement.
Young Scientists Congress: New technologies take centerstage at science exhibition in Wenzhou
The World Young Scientists Congress has opened in Wenzhou, east China's Zhejiang Province. More than 800 scientists and entrepreneurs from over 60 countries and regions are attending the event which includes an exhibition of the latest technologies. We spoke with some of the visitors to the event.
Autism study reveals neural circuit supporting flexible learning
Researchers have identified a brain circuit linked to the flexible formation of memories that may help explain some of the differences in learning associated with autism spectrum disorder.
2026 KlarText Prize for Science Communication: Klaus Tschira Foundation Honors Seven Researchers
What exactly did you do in your doctoral dissertation? The Klaus Tschira Foundation honors the most compelling answers to this question with the KlarText Prize for Science Communication. On Octobe ...
Women Appear to Experience Psychedelic Drugs More Intensely, And We Don't Know Why
Same dose, different experience.
Teddy Roosevelt Erred on Neanderthals
Just recently, paleontologists have found Neanderthal wooden tools (62-40 kya) preserved in stone.
Families celebrate Halloween with a side of science at Nature Museum
The Peggy Notebaert Nature Museum invited families to its annual BOO-seum Bash Sunday, with animal encounters, hands-on activities and plenty of Halloween fun.
Over 300 students learn science and technology at CCSD Family STEM Day
Over 300 students learned about science and technology industries at the Clark County School District Magnet Schools Family STEM Day on Saturday.STEM Day as he
Scientists trapped antimatter particle for months -- but studying it without blowing up lab was a challenge
Is an Academy of Natural Sciences divorce coming?
Hearings for the museum are coming Monday. Will it make a difference?
Scientists Discovered an Amazing Practical Use For The World's Leftover Coffee Grounds
We shouldn't throw it out.
Scientists Discovered an Amazing Practical Use For The World's Leftover Coffee Grounds
We shouldn't throw it out.
Science 4 Everyone: How does sod and tall fescue work?
Science teacher and Storm Team4 Meteorologist Ryan Miller explains how to use sod in your yard to prepare for cooler weather.
Binaytara Implementation Science Research Awards 2027 - Oncology News, Insights, Stories by OncoDaily
The Binaytara Implementation Science Research Awards 2027 provide up to $25,000 per project to support early-career investigators improving how evidence-based
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced by cancer cells to manufacture anticancer drugs directly inside them. The approach relies on carbon monoxide, a toxic gas that certain
Professor Katherine McNeill Inducted Into Massachusetts Science Educators Hall of Fame
Katherine L. McNeill was inducted into the Massachusetts Science Educators Hall of Fame on Friday in recognition of her two decades of work in science education.
Scientists Discover How Excess RNA Can Disrupt the Energy Supply Inside Cells
Scientists at Texas A&M University discovered that excess RNA can interfere with the machinery cells use to produce energy, even without triggering certain immune defenses. The findings reveal an unex...
Cattle Science Gets a $19.5 Million Upgrade as West Texas A and M Plans High-Tech Research Complex
West Texas A&M is building a $19.5M cattle research complex featuring AI technology, veterinary research and commercial-scale feedlot studies.
Warren, Steelers stiff-arm Saints for 16-10 Paris win
Jaylen Warren had another big day and the Pittsburgh Steelers overcame some red-zone inefficiency to beat the New Orleans Saints.
Looking back: And a happy Halloween to you too
Ward’s science supply in Monterey was once the go-to stop for various skeleton parts.
Orlando Science Center hosts Halloween party
Adults can enjoy an open bar, laser shows, and more at the Orlando Science Center's Halloween After Dark on October 31.
Orlando Science Center hosts Halloween party
Adults can enjoy an open bar, laser shows, and more at the Orlando Science Center's Halloween After Dark on October 31.
Photographer and medical professionals connect science and art during panel discussion
In 2020, the world was put on hold because COVID-19 began claiming the lives of people all over the globe. When a vaccination for the illness was finally made public in 2021, being vaccinated became highly politicized. Instead of focusing on the emotional reactions that people had toward the vaccine, artist Linda Alterwitz was more...
Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science
Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair.
Scientists Discover a Plant Compound That Could Help Stop Rheumatoid Arthritis Inflammation
Scientists have identified a plant compound that reduced joint swelling and inflammation in rats with experimental arthritis. The discovery offers a potential new direction for rheumatoid arthritis tr...
#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
Merck and Moderna’s intismeran cut melanoma recurrence risk 42% at ESMO; experts weigh other tumors, manufacturing and boosters.
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
Scientists Found One of The 'Chunkiest' Squid-Like Creatures Ever Known
A "thick and peculiar" cephalopod.
Scientists Find Chronic Back Pain Activates a Brain Network Linked to Personal Identity
A new UC San Diego brain imaging study involving 114 adults suggests that chronic back pain flare-ups affect brain networks involved in self-reflection and personal memories. The findings may help exp...
The science and politics behind the panic over ultraprocessed foods
The very definition of ultraprocessed is highly contested.
Ranked: Countries With the Most Trust in Science
Discover which countries trust science the most and least in 2025, and how education, religion, and culture shape public confidence.
Opinion - How Trump learned to stop worrying and love space science
He recognizes a cool thing when he sees it.
Science Snapshots: October 25, 2026
Three key science updates in one minute: Starry Night’s dawn matched to Jul 22, 1889; cold boosts lifespan via BH2/BH4; cluster similar-buildings cools cities.
A simple liquid can stop cavities without drilling, major study confirms
A simple liquid painted onto teeth in seconds can stop cavities without drilling, injections, or anesthesia, according to a major clinical trial involving young children. The inexpensive treatment could spare thousands of children painful dental procedures and surgery while paving the way for broader FDA-approved use.
Scientists overcome a hidden obstacle to more powerful quantum computers
Scientists have discovered a way to operate multiple silicon qubits simultaneously with remarkable accuracy, overcoming a major challenge in scaling up quantum computers. Their new technique maintained accuracy of approximately 99.9% even when all five qubits were running at once, opening the door to larger and more powerful quantum processors.
Scientists reveal the hidden danger of missing blood pressure medication
Missing blood pressure medication could mean losing much of its protection against heart attacks and strokes, according to an analysis of more than 91,000 people. Patients who consistently took their medication experienced an 11% reduction in major cardiovascular events, while those who missed too many doses saw little or no measurable benefit.
Just two drinks a day may be far riskier than you think
A major new study reveals that drinking just two alcoholic beverages a day is associated with a 1 in 25 lifetime risk of death from alcohol-related causes, challenging the idea that moderate drinking is harmless. Researchers also found no significant overall health benefits from alcohol, with risks rising as consumption increases.
Three giant black holes discovered in a galaxy from the dawn of time
Astronomers have discovered three actively feeding black holes inside a single galaxy more than 12.5 billion light-years away, revealing a remarkable scene from the universe’s infancy. Two of the black holes are separated by just 620 light-years and are expected to eventually merge, while a third lurks farther away. One weighs an astonishing 80 million suns, and another is growing faster than conventional theories predict.
Just two drinks a day may be far riskier than you think
A major new study reveals that drinking just two alcoholic beverages a day is associated with a 1 in 25 lifetime risk of death from alcohol-related causes, challenging the idea that moderate drinking is harmless. Researchers also found no significant overall health benefits from alcohol, with risks rising as consumption increases.
Scientists Trapped an Antimatter Particle for Months to Study Its Secrets
These elusive and reactive particles have been challenging to hold on to and even more challenging to study, but a new method paves the way for tests on the differences between matter and antimatter.
Polish team unearths ancient human remains and mystery giraffe skull in Tanzania
The discoveries could shed new light on how prehistoric communities lived, migrated and treated their dead.
Antarctica’s “Doomsday Glacier” Could Raise Sea Levels Twice As Much as Scientists Feared
Even without further warming, Thwaites Glacier could contribute twice as much to sea level rise by 2100 as previously estimated, according to a revised ice sheet model. Thwaites Glacier in West Antarctica has been retreating and thinning rapidly, while satellites show substantial acceleration in its ice flow. Traditional ice sheet models have depicted slower movement,
As vote nears, Trump’s AI gamble fuels economic uncertainty
Some of the world’s leading financiers are sounding increasingly alarmed about an AI bubble.
Why partisan politics may be changing people's accents
With the midterms fast approaching, communicating just the right message has been top of mind on all sides of the political aisle
How the Romans Invented Apartment Living. It Was Brilliant, Brutal, and Often Deadly
Long before modern cities built upward, Rome learned how to stack human lives.
‘Once we lose these, they’re gone forever’: What will become of the dioramas at the Academy of Natural Sciences?
The museum’s closure could endanger the 32 dioramas. Moving them can cost millions.
Why scientists no longer think plastic is the safest material around
For decades, scientists believed that plastics were some of the safest materials around. Now it's clear how flawed that view was.
Scientists Simulated Solar Explosions in The Lab – And May Have Solved One of The Sun's Biggest Mysteries
A fiery paradox.
Scientists Simulated Solar Explosions in The Lab – And May Have Solved One of The Sun's Biggest Mysteries
A fiery paradox.
Why crafting is good for your brain, according to science
Knitters and other crafters say busy hands quiet their minds. But experts say there are also benefits for cognition.
‘It’s magic’: scientists rediscover how to make ancient Roman colour-changing glass
Exclusive: Optical engineering that went into 1,600-year-old Lycurgus Cup has baffled experts for centuries
Union to Dedicate Historic Marker Commemorating Battle of Connecticut Farms as Part of America's 250th Celebrations
Union – The Township of Union Planning Committee for the 250th Anniversary of the United States, in partnership with the Union Township Historical Society, invites residents and history enthusiasts...
VT Science Corner: Expanding eating disorder care to rural areas
The great Taylor Swift proclaimed “I’m the problem, it’s me” in her 2022 song, "Anti-Hero." This lyric reflects something many people can recognize: the belief that something is fundamentally wrong
Clifton ‘Jackie’ Jackson: A towering gentleman of the bass
Clifton ‘Jackie’ Jackson embodies Robert Farris Thompson’s classic concept of the ‘aesthetic of the cool’, also referred to by the ancient Yoruba concept of itutu. He was the elegant bassist whose lines were as refined as his demeanour. Calling him the ‘Rolls-Royce of Reggae Bassists’ isn’t to suggest he didn’t roll with some of the deepest, lilting roots grooves like others. He added an unmatched touch, poise and musical sophistication to the bottom end while retaining every bit of the heavy, syncopated pulse required for authentic Jamaican music.
Overnight Science News: Over 76% of Americans can’t name a living scientist
This week’s science news roundup begins with climate change drama then continues with (mostly) happier topics like dinosaurs, butterflies, and lizard tails in amber. Please add your contributions in a…
Science Hill lost in the TSSAA state volleyball finals on Friday
Franklin's win capped a banner day for Nashville-area Division I programs as they teams swept the Class A (Eagleville), AA (Valor Prep) and AAA championships.
Science and Sense: The big election column
Although Science and Sense tries to avoid politics, we have an important election soon, and this is, after all, an Opinion column. It might be argued that “Political Science” is
Neuroscientist discusses how alcohol can affect brain volume and long-term health
Josh Gowin explains how research has shifted the understanding of alcohol's health risks, including its association with reduced brain volume, as drinking habits and social norms continue to change.
NMSU research centers celebrate fall with outreach events
NMSU agricultural science centers hosted fall learning events featuring farm demonstrations, pumpkin patches and hands-on activities for elementary students.